Injection of a substance to block an artery feeding the dura (protective sack around the brain) along with surgery to remove pooled blood reduced the risk that patients will require repeat surgery compared to surgical drainage alone, according to preliminary late-breaking science presented today at the American Stroke Association’s International Stroke Conference 2024.
Regeneron’s $500M fund spotlights corporate venture’s influential role in biotech
When Regeneron announced a $500 million corporate venture capital fund last week, it was the first time in years that a storied large pharma had
April 23, 2024